Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Differential aging trends among Liver Transplant candidates with and without hepatocellular carcinoma.
Material economic hardship is associated with adverse 1-year outcomes after pediatric liver transplantation: Prospective cohort results from the multi-center SOCIAL-Tx study.
Enhancing the prognostic accuracy of the RETREAT score with AFP-L3 and DCP tumor markers.
Sociodemographic disparities in downstaging to liver transplant for hepatocellular carcinoma.
Clinical outcomes in patients with unintended pregnancy after liver transplantation: A multicenter registry cohort study.
Analysis of treatment benefits and prognostic factors for Post-Transplant hepatocellular carcinoma recurrence in a large Euro-American-Asian cohort.
The liver frailty index enhances mortality risk prediction above and beyond MELD 3.0 alone.
Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among decompensated cirrhosis patients.
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.
Clinically relevant cut-points for changes in the Liver Frailty Index are associated with waitlist mortality in patients with cirrhosis.
